MedTrace Logo

GraviD-child Follow-up of the Children´s Health, Growth and Development Within the GraviD-study

NCT05228925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 172

Last updated 2023-09-18

No results posted yet for this study

Summary

GraviD is a multi-ethnic population-based pregnancy cohort. Pregnant women were invited to participate in the GraviD study when registering for antenatal care in parts of the region of Västra Götaland in Sweden in 2013-2014. All women registering for antenatal care were eligible for inclusion, as long as the pregnancy had not exceeded 16 gestational weeks. In total, 2125 pregnant women were recruited in gestational week 12 during two time-periods; fall 2013 and spring 2014. Blood sampling was performed in gestational week \<17 and again at gestational week \>31 by midwifes. After delivery, the maternity records were obtained, to collect information on child's gender, birth weight and length and other possible birth outcomes.

Conditions

  • Vitamin D Deficiency
  • Body Composition
  • Vascular Health
  • Cardiometabolic Risk

Interventions

OTHER

Maternal vitamin D status

Maternal vitamin D status (serum 25-hydroxyvitamin D) was collected during the GraviD study, while the woman was pregnant with the child now being followed-up in the GraviD-child study

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Norwegian Institute of Public Health

    collaborator OTHER_GOV

  • Göteborg University

    lead OTHER

Principal Investigators

  • Hanna Augustin, Ass Prof · Göteborg University

Eligibility

Min Age
7 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-01-01
Completion
2023-02-14

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05228925 on ClinicalTrials.gov